Product Images Alendronate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Alendronate NDC 50090-3593 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph or chart showing the cumulative incidence of something over time (in months) with two treatments: Placebo and Alondronate Sodium. The percentage shown is 10. Unfortunately, without additional context or information, it is difficult to determine what exactly the graph represents.*
This appears to be a table with headings related to changes in BMD (Bone Mineral Density) from baseline in a study over 2 and 3 years, comparing Alendronate Sodium 5mg/day and Placebo. The table contains data related to Lumbar Spine, Femoral Trochanter, Total Neck and Body.*
This is a table that shows the mean percentage change in serum alkaline phosphatase from baseline for different treatments in a study conducted over the course of three months. The treatments include a placebo, etidronate 400 mg/day, and two doses of alendronate sodium (40 mg/day) from two different studies - one conducted internationally and another one conducted in the United States.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.